140 related articles for article (PubMed ID: 3547908)
1. Preservation effect on oligo-anuria in the cyclosporine era: a prospective trial with 26 paired cadaveric renal allografts.
Mendez R; Mendez RG; Koussa N; Cats S; Bogaard TP; Khetan U
Transplant Proc; 1987 Feb; 19(1 Pt 3):2047-50. PubMed ID: 3547908
[No Abstract] [Full Text] [Related]
2. The effect of cyclosporine on the early postoperative function of allografted kidneys with warm ischemic damage.
Ohshima S; Fujita T; Asano H; Ono Y
Transplant Proc; 1987 Feb; 19(1 Pt 3):2081-4. PubMed ID: 3547911
[No Abstract] [Full Text] [Related]
3. Serum beta 2 microglobulin monitoring in cadaver kidney transplant recipients with oliguric renal failure.
Schweizer RT; Roper L; Hull D; Bartus S
Transplant Proc; 1989 Feb; 21(1 Pt 2):1867-8. PubMed ID: 2652607
[No Abstract] [Full Text] [Related]
4. Delayed graft function following cadaver renal transplantation in the cyclosporine era: analysis of acute rejection and graft survival.
Bauma WD; Tang IY; Maddux MS; Veremis SA; Pollak R; Mozes MF
Transplant Proc; 1989 Feb; 21(1 Pt 2):1276-7. PubMed ID: 2652422
[No Abstract] [Full Text] [Related]
5. A Japanese trial of cyclosporine in living related and cadaveric renal transplantation.
Ochiai T; Toma H; Oka T; Takagi H; Kashiwabara H; Ishibashi M; Fukao K; Ota K; Hashimoto I; Sonoda T
Transplant Proc; 1985 Aug; 17(4):2035-40. PubMed ID: 3895651
[No Abstract] [Full Text] [Related]
6. The impact of immunological risk factors on the outcome of cadaveric renal transplantation as revealed in transplants with primary graft anuria.
Madsen M; Fjeldborg O; Rasmussen A; Povlsen JV; Kissmeyer-Nielsen F
Transplant Proc; 1990 Aug; 22(4):1371-2. PubMed ID: 2389332
[No Abstract] [Full Text] [Related]
7. Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.
Fries D; Hiesse C; Charpentier B; Rieu P; Neyrat N; Cantarovich M; Ouziala M; Bellamy J; Benoit G
Transplant Proc; 1987 Feb; 19(1 Pt 3):1911-4. PubMed ID: 3547895
[No Abstract] [Full Text] [Related]
8. Calcium antagonist treatment of recipients minimizes early cyclosporine nephrotoxicity in renal transplantation: a prospective randomized trial.
Morales JM; Andrés A; Prieto C; Ortuño B; Estenoz J; Dorado C; Arenas J; Ruilope LM; Fernández-Cruz L; Rodicio JL
Transplant Proc; 1989 Feb; 21(1 Pt 2):1537-9. PubMed ID: 2652496
[No Abstract] [Full Text] [Related]
9. The intake of initially high doses of cyclosporine A in cadaveric kidney transplantation is not justified. Results of a prospective study.
Niebel W; Albrecht KH; Metz K; Jakubowski HD; Windeck R; Eigler FW
Transplant Proc; 1988 Feb; 20(1 Suppl 1):394-7. PubMed ID: 3279628
[No Abstract] [Full Text] [Related]
10. Role of HLA matching and pretransplant blood transfusions in cyclosporine-treated recipients of cadaveric renal allografts: 2- to 3-year results.
Lundgren G; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Gäbel H; Lindholm A; Maurer W; Möller E; Persson H
Transplant Proc; 1987 Oct; 19(5):3614-8. PubMed ID: 3313870
[No Abstract] [Full Text] [Related]
11. Sequential therapy with anti-thymocyte globulin and cyclosporine A in oligoanuric high-risk cadaveric kidney graft recipients.
Valderrábano F; Anaya F; Robles NR; Jofré R
Transplant Proc; 1988 Oct; 20(5 Suppl 6):75-8. PubMed ID: 3051597
[No Abstract] [Full Text] [Related]
12. Japanese Multicenter Trial of Cyclosporine in Renal Transplantation: overall results and analysis of the factors influencing graft survival rate.
Ochiai T; Toma H; Takagi H; Oka T; Ishibashi M; Kashiwabara H; Fukao K; Ota K; Hashimoto I; Sonoda T
Transplant Proc; 1987 Apr; 19(2):2961-6. PubMed ID: 3551242
[No Abstract] [Full Text] [Related]
13. Trial of cyclosporine vs OG37-325 in cadaveric renal transplantation: a preliminary report.
Henry ML; Tesi RJ; Elkhammas EA; Ferguson RM
Transplant Proc; 1993 Feb; 25(1 Pt 1):689-90. PubMed ID: 8438438
[No Abstract] [Full Text] [Related]
14. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
Chapman JR; Morris PJ
Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
[No Abstract] [Full Text] [Related]
15. Improved early course after cadaveric renal transplantation by reducing the cyclosporine dose and adding azathioprine.
Lundgren G; Albrechtsen D; Brynger H; Flatmark A; Frödin I; Gäbel H; Persson H; Groth CG
Transplant Proc; 1987 Feb; 19(1 Pt 3):2074-9. PubMed ID: 3547910
[No Abstract] [Full Text] [Related]
16. Update for the Canadian multicentre trial of cyclosporine in renal allografts.
Stiller CR
N Engl J Med; 1984 May; 310(22):1464-5. PubMed ID: 6371537
[No Abstract] [Full Text] [Related]
17. Verapamil prevents post-transplant oliguric renal failure.
Duggan KA; Macdonald GJ; Charlesworth JA; Pussell BA
Clin Nephrol; 1985 Dec; 24(6):289-91. PubMed ID: 3907910
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine therapy independent of graft diuresis in cadaveric renal transplants.
Taylor RJ; Zheng S; Ptachinski R; Rosenthal JT; Hakala TR
Transplant Proc; 1986 Apr; 18(2 Suppl 1):5-7. PubMed ID: 3515694
[No Abstract] [Full Text] [Related]
19. Cyclosporin A efficacy and toxicity in organ transplantation with special focus on cadaveric renal transplantation.
Lesne M; Squifflet JP; Wallemacq P; Lenain F; Alexandre G
Chemioterapia; 1985 Oct; 4(5):400-5. PubMed ID: 3907864
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin A in clinical kidney grafting from cadaver donors.
Calne RY; White DJ; Thiru S; Evans DB; McMaster P; Dunn DC; Craddock GN; Rolles K
Proc Eur Dial Transplant Assoc; 1979; 16():305-9. PubMed ID: 398499
[No Abstract] [Full Text] [Related]
[Next] [New Search]
